It is alleged in the complaint that GoodRx issued misleading and/or false statements and/or failed to disclose information pertinent to investors at the time of GoodRx’s initial public stock offering (the “IPO”). Specifically, it is alleged that GoodRx completed its IPO, selling about 34.6 million shares at $33.00 per share on September 23, 2020. It is alleged that Defendants timed the IPO before Amazon announced its online pharmaceutical business, which makes their statements in the Registration Statement and during the Class Period regarding the competitive position of GoodRx materially misleading and/or false. Due to these materially misleading and/or false statements, it is alleged that during the Class Period GoodRx Class A common stock traded at artificially inflated prices of more than $64 per share.

Then, on November 17, 2020, Amazon announced its Prime Rx plan along with a discount card program, which was said to make it “simple for customers to compare prices and purchase medications for home delivery, all in one place.” On November 17, 2020 GoodRx Class A common stock dropped 23%, from $46.72 per share to $36.21, following this news.

GoodRx Holdings, Inc.

Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to

Are you a current or former employee of the company?*YesNo


+Additional Purchases


+Additional Sales

If you prefer, you may submit your transaction information or comments/questions in the box below:

There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.

We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at, or by email at

If you choose to take no action, you can remain an absent class member.

Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.

The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Portnoy Law Firm
Lesley F. Portnoy, Esq.,
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067